Rothschild Investment LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Rothschild Investment LLC’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185K	Buy	13,300 +7	+0.1%	+$112	0.01%	697
2025 Q4	$216K	Buy	13,293 +3,013	+29%	+$49.2K	0.01%	597
2025 Q3	$154K	Sell	10,280 -70	-0.7%	-$853	0.01%	687
2025 Q2	$121K	Buy	10,350 +45	+0.4%	+$409	0.01%	603
2025 Q1	$76.6K	Buy	10,305 +70	+0.7%	+$538	0.01%	679
2024 Q4	$61.4K	Buy	10,235 +25	+0.2%	+$138	﹤0.01%	743
2024 Q3	$52.3K	Buy	10,210 +170	+2%	+$741	﹤0.01%	764
2024 Q2	$36.3K	Buy	10,040 +40	+0.4%	+$127	﹤0.01%	829
2024 Q1	$32.1K	Hold	10,000	–	–	﹤0.01%	822
2023 Q4	$49K	Hold	10,000	–	–	﹤0.01%	659
2023 Q3	$55K	Buy	+10,000	New	+$66.1K	﹤0.01%	469
2021 Q4	–	Sell	-6,000	Closed	-$204K	–	502
2021 Q3	$204K	Buy	6,000 +1,000	+20%	+$36.2K	0.02%	457
2021 Q2	$204K	Hold	5,000	–	–	0.02%	460
2021 Q1	$201K	Buy	+5,000	New	+$271K	0.02%	443
2020 Q4	–	Sell	-7,000	Closed	-$340K	–	453
2020 Q3	$340K	Buy	+7,000	New	+$294K	0.04%	318

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rothschild Investment LLC's ADPT Position: Q1 2026 in Review

Rothschild Investment LLC increased its Adaptive Biotechnologies (ADPT) stake by 0.05% in Q1 2026, buying an estimated $112 and bringing the position to 13,300 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #697.

Rothschild Investment LLC first reported a position in ADPT in Q3 2020 and has held it in 15 quarters since. The position peaked at $340K in Q3 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Rothschild Investment LLC held 13,300 shares of Adaptive Biotechnologies worth $185K as of Q1 2026.
Rothschild Investment LLC bought 7 Adaptive Biotechnologies shares in Q1 2026, an estimated $112.
Adaptive Biotechnologies made up 0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #697 holding.
Rothschild Investment LLC first reported a position in Adaptive Biotechnologies in Q3 2020 and has held it in 15 quarters since.
Rothschild Investment LLC's Adaptive Biotechnologies position peaked at $340K in Q3 2020.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.